Andrew Davis - Silk Road Chief Officer
| SILKDelisted Stock | USD 27.49 0.00 0.00% |
Insider
Andrew Davis is Chief Officer of Silk Road Medical
| Age | 55 |
| Phone | 408 720 9002 |
| Web | https://silkroadmed.com |
Andrew Davis Latest Insider Activity
Tracking and analyzing the buying and selling activities of Andrew Davis against Silk Road stock is an integral part of due diligence when investing in Silk Road. Andrew Davis insider activity provides valuable insight into whether Silk Road is net buyers or sellers over its current business cycle. Note, Silk Road insiders must abide by specific rules, including filing SEC forms every time they buy or sell Silk Road'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Andrew Davis over three months ago Disposition of tradable shares by Andrew Davis of Silk Road at 27.0021 subject to Rule 16b-3 | ||
Andrew Davis over three months ago Disposition of 6189 shares by Andrew Davis of CPI Aerostructures subject to Rule 16b-3 |
Silk Road Management Efficiency
The company has return on total asset (ROA) of (0.1411) % which means that it has lost $0.1411 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3645) %, meaning that it created substantial loss on money invested by shareholders. Silk Road's management efficiency ratios could be used to measure how well Silk Road manages its routine affairs as well as how well it operates its assets and liabilities.Silk Road Medical currently holds 84.63 M in liabilities with Debt to Equity (D/E) ratio of 1.37, which is about average as compared to similar companies. Silk Road Medical has a current ratio of 6.78, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Silk Road's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Thomas MD | Inari Medical | 51 | |
| Alex Shvartsburg | LivaNova PLC | 54 | |
| Derrick Sung | Pulmonx Corp | 51 | |
| John Treace | Treace Medical Concepts | 52 | |
| Michael Favet | Neuropace | 54 | |
| Dena Truelove | Inari Medical | N/A | |
| Lindsey Little | LivaNova PLC | N/A | |
| Jason Edie | Paragon 28 | N/A | |
| Jaime Frias | Treace Medical Concepts | 62 | |
| Geoffrey Rose | Pulmonx Corp | 50 | |
| Tamer MD | TransMedics Group | 55 | |
| Steve Deitsch | Paragon 28 | N/A | |
| Joseph Powers | Si Bone | 64 | |
| Andrew Hykes | Inari Medical | 51 | |
| Mark CPA | Treace Medical Concepts | 54 | |
| William Hoffman | Inari Medical | 57 | |
| Meghan Scanlon | Paragon 28 | 48 | |
| Thomas Timbie | Treace Medical Concepts | 66 | |
| B Johnson | Paragon 28 | 68 | |
| Sri Radhakrishnan | Pulmonx Corp | N/A | |
| Lauren Cristina | Pulmonx Corp | N/A | |
Management Performance
| Return On Equity | -0.36 | |||
| Return On Asset | -0.14 |
Silk Road Medical Leadership Team
Elected by the shareholders, the Silk Road's board of directors comprises two types of representatives: Silk Road inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Silk. The board's role is to monitor Silk Road's management team and ensure that shareholders' interests are well served. Silk Road's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Silk Road's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Erica Rogers, President CEO, Director | ||
| Sumaira Macdonald, Chief Medical Officer | ||
| Mhairi Jones, VP Accounting | ||
| Sumaira MD, Executive Director | ||
| Kevin Ballinger, Chief Sec | ||
| Tammy Leitsinger, Compliance Affairs | ||
| Kevin Klemz, Chief EVP | ||
| Alison Highlander, Vice Resources | ||
| Jorge OHara, Business Marketing | ||
| Charles McKhann, Chief Officer | ||
| Richard Ruedy, Executive Vice President - Regulatory Affairs, Clinical Affairs & Quality Assurance | ||
| Lucas Buchanan, CFO COO | ||
| Lynn Lewis, Investors Officer | ||
| Andrew Davis, Chief Officer | ||
| Matthew McCarthy, Vice Marketing |
Silk Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Silk Road a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.36 | |||
| Return On Asset | -0.14 | |||
| Profit Margin | (0.30) % | |||
| Operating Margin | (0.34) % | |||
| Current Valuation | 1.02 B | |||
| Shares Outstanding | 40.63 M | |||
| Shares Owned By Insiders | 4.15 % | |||
| Shares Owned By Institutions | 97.46 % | |||
| Number Of Shares Shorted | 3.15 M | |||
| Price To Book | 7.22 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Consideration for investing in Silk Stock
If you are still planning to invest in Silk Road Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Silk Road's history and understand the potential risks before investing.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |